Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

healthcare

  • Home
  •  
  • healthcare



  • Most Read
  • Latest Comments
  • High-touch, high-quality maternity care could soon become standard in major hospitals
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • High-touch, high-quality maternity care could soon become standard in major hospitals
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • High-touch, high-quality maternity care could soon become standard in major hospitals
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • High-touch, high-quality maternity care could soon become standard in major hospitals
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • High-touch, high-quality maternity care could soon become standard in major hospitals
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    PainChek locks in performance data for FDA submission, aiming to be first pain assessment app approved in US
    • News

  • HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    • News

  • BTC Health secures $5m ECMO contract with Royal Children’s Hospital for life-saving medtech
    BTC Health secures $5m ECMO contract with Royal Children’s Hospital for life-saving medtech
    • News

  • BTC Health drives earnings with product diversification to all major hospital operators
    BTC Health drives earnings with product diversification to all major hospital operators
    • News

  • Bioxyne leads the way as Australia’s first manufacturer of pharmaceutical cannabis gummies
    Bioxyne leads the way as Australia’s first manufacturer of pharmaceutical cannabis gummies
    • News

  • High-touch, high-quality maternity care could soon become standard in major hospitals
    • News

    High-touch, high-quality maternity care could soon become standard in major hospitals

    Bringing telehealth to expectant mothers that will rival major hospital facilities, medtech company HeraMED (ASX: HMD) is taking a significant step forward in the commercialisation of their foetal monitoring device. As part of their Technology as a Service (TaaS) recurring revenue model, the Company has entered into an agreement with Joondalup Health Campus (JHC) which

    Read More
    Public
  • InteliCare launches aged care remote dashboard to track health of dependants
    • News

    InteliCare launches aged care remote dashboard to track health of dependants

    Continuing to leverage their healthcare technology, InteliCare (ASX: ICR) is furthering its push to give aged care residents privacy and autonomy while ensuring health standards can be maintained where loved ones will be able to track their condition remotely. The launch of InteliLiving health metrics will enable those living independently to have health data uploaded

    Read More
    Public
  • ResApp granted European approval for wearable cough assessment device
    • News

    ResApp granted European approval for wearable cough assessment device

    Amid the growing concerns around coughing in public for the obvious reason, medtech company ResApp Health (ASX: RAP) has secured regulatory approval in Europe for their wearable device that analyses a person’s cough and the medical implications. The device, which is yet to be named, can be easily clipped on to a person’s shirt where

    Read More
    Public
  • Healthia earnings up 91% as pandemic boosts Aussie health consciousness
    • News

    Healthia earnings up 91% as pandemic boosts Aussie health consciousness

    As the world emerges from a pandemic, Australians are proving to be more conscious of their general health than ever as evidenced by allied health company Healthia (ASX: HLA) which has delivered shareholders a 91% increase in underlying EBITDA.  The bumper result was driven by 14.5% organic growth across the Group whose clinics continue to

    Read More
    Public
  • Healthia eyes off more acquisitions with NAB partnership, increases facility to $70m
    • News

    Healthia eyes off more acquisitions with NAB partnership, increases facility to $70m

    Capitalising on favourable economic conditions, allied healthcare company Healthia (ASX: HLA) has partnered with National Australia Bank (ASX: NAB) to increase their finance facility by $20 million which will be deployed towards allied health acquisitions for the rapidly growing service provider.  The partnership increases Healthia’s existing finance facility from $50m to $70m and will see

    Read More
    Public
  • MyFiziq inks Tinjoy deal to access 28 million new customers in China
    • News

    MyFiziq inks Tinjoy deal to access 28 million new customers in China

    Health tech company MyFiziq (ASX: MYQ) is making rapid inroads into the lucrative health-conscious Chinese market having signed terms with Tinjoy Biotech to secure direct access to their 28 million consumers. The deal will see MyFiziq’s CompleteScan app integrated with Tinjoy’s WinScan Digital Health Platform where MyFiziq will utilise Tinjoy’s call centre of almost 1,000

    Read More
    Public
  • «
  • ‹
  • 7
  • 8
  • 9
  • 10
  • 11
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.